Literature DB >> 22822035

Mechanistic studies on the absorption and disposition of scutellarin in humans: selective OATP2B1-mediated hepatic uptake is a likely key determinant for its unique pharmacokinetic characteristics.

Chunying Gao1, Hongjian Zhang, Zitao Guo, Tiangeng You, Xiaoyan Chen, Dafang Zhong.   

Abstract

Scutellarin [scutellarein-7-O-glucuronide (S-7-G)] displayed a unique pharmacokinetic profile in humans after oral administration: the original compound was hardly detected, whereas its isomeric metabolite isoscutellarin [scutellarein-6-O-glucuronide (S-6-G)] had a markedly high exposure. Previous rat study revealed that S-7-G and S-6-G in the blood mainly originated from their aglycone in enterocytes, and that the S-7-G/S-6-G ratio declined dramatically because of a higher hepatic elimination of S-7-G. In the present study, metabolite profiling in human excreta demonstrated that the major metabolic pathway for S-6-G and S-7-G was through further glucuronidation. To further understand the cause for the exposure difference between S-7-G and S-6-G in humans, studies were conducted to uncover mechanisms underlying their formation and elimination. In vitro metabolism study suggested that S-7-G was formed more easily but metabolized more slowly in human intestinal and hepatic microsomes. Efflux transporter study showed that S-6-G and S-7-G were good substrates of breast cancer resistance protein and multidrug resistance-associated protein (MRP) 2 and possible substrates of MRP3; however, there was no preference great enough to alter the S-7-G/S-6-G ratio in the blood. Among the major hepatic anion uptake transporters, organic anion-transporting polypeptide (OATP) 2B1 played a predominant role in the hepatic uptake of S-6-G and S-7-G and showed greater preference for S-7-G with higher affinity than S-6-G (K(m) values were 1.77 and 43.9 μM, respectively). Considering the low intrinsic permeability of S-6-G and S-7-G and the role of OATP2B1 in the hepatic clearance of such compounds, the selective hepatic uptake of S-7-G mediated by OATP2B1 is likely a key determinant for the much lower systemic exposure of S-7-G than S-6-G in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22822035     DOI: 10.1124/dmd.112.047183

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.579


  17 in total

1.  In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).

Authors:  Xingxing Diao; Jeremy Carlier; Mingshe Zhu; Shaokun Pang; Robert Kronstrand; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Forensic Toxicol       Date:  2016-07-06       Impact factor: 4.096

2.  Hepatic Transport of 25-Hydroxyvitamin D3 Conjugates: A Mechanism of 25-Hydroxyvitamin D3 Delivery to the Intestinal Tract.

Authors:  Chunying Gao; Michael Z Liao; Lyrialle W Han; Kenneth E Thummel; Qingcheng Mao
Journal:  Drug Metab Dispos       Date:  2018-02-21       Impact factor: 3.922

3.  Elucidation of the Mechanisms through Which the Reactive Metabolite Diclofenac Acyl Glucuronide Can Mediate Toxicity.

Authors:  Renato J Scialis; José E Manautou
Journal:  J Pharmacol Exp Ther       Date:  2016-02-11       Impact factor: 4.030

4.  Potential role of organic anion transporting polypeptide 1B1 (OATP1B1) in the selective hepatic uptake of hematoporphyrin monomethyl ether isomers.

Authors:  Xiu-li Li; Zi-tao Guo; Ye-dong Wang; Xiao-yan Chen; Jia Liu; Da-fang Zhong
Journal:  Acta Pharmacol Sin       Date:  2014-11-24       Impact factor: 6.150

5.  Scutellarin suppresses human colorectal cancer metastasis and angiogenesis by targeting ephrinb2.

Authors:  Ping Ting Zhu; Ming Mao; Zhao Guo Liu; Li Tao; Bing Chun Yan
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

6.  In Vitro and In Vivo Human Metabolism of Synthetic Cannabinoids FDU-PB-22 and FUB-PB-22.

Authors:  Xingxing Diao; Karl B Scheidweiler; Ariane Wohlfarth; Shaokun Pang; Robert Kronstrand; Marilyn A Huestis
Journal:  AAPS J       Date:  2016-01-25       Impact factor: 4.009

7.  Disposition of flavonoids via recycling: Direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides.

Authors:  Min Zeng; Rongjin Sun; Sumit Basu; Yong Ma; Shufan Ge; Taijun Yin; Song Gao; Jun Zhang; Ming Hu
Journal:  Mol Nutr Food Res       Date:  2016-04-13       Impact factor: 5.914

8.  Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart.

Authors:  Xi-Peng Sun; Li-Li Wan; Quan-Jun Yang; Yan Huo; Yong-Long Han; Cheng Guo
Journal:  Arch Pharm Res       Date:  2017-03-17       Impact factor: 4.946

9.  Interaction of silymarin flavonolignans with organic anion-transporting polypeptides.

Authors:  Kathleen Köck; Ying Xie; Roy L Hawke; Nicholas H Oberlies; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2013-02-11       Impact factor: 3.922

10.  Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes.

Authors:  Xingxing Diao; Karl B Scheidweiler; Ariane Wohlfarth; Mingshe Zhu; Shaokun Pang; Marilyn A Huestis
Journal:  Forensic Toxicol       Date:  2016-03-28       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.